Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

Nature communications·2026
Same author

Class 3 MAP2K1 mutations are associated with frequent relapse and multiple treatment lines in multi-system Langerhans cell histiocytosis.

Blood advances·2026
Same author

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

HemaSphere·2026
Same author

CD117-targeted HCT preconditioning in AML and MDS.

Blood·2026
Same author

A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.

Molecular cancer therapeutics·2026
Same author

Extracorporeal photopheresis alone or in combination with ruxolitinib for the treatment of chronic graft-versus-host disease.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jan 9, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.7K

Humanized hemato-lymphoid system mice.

Alexandre P A Theocharides1, Anthony Rongvaux2, Kristin Fritsch1

  • 1Hematology, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland.

Haematologica
|January 2, 2016
PubMed
Summary

Humanized mice are crucial research tools for studying blood disorders. Advances in xenograft models improve preclinical therapy development for human hematology and immunology.

More Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.8K
Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.5K

Related Experiment Videos

Last Updated: Jan 9, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.7K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.8K
Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.5K

Area of Science:

  • Hematology
  • Immunology
  • Xenotransplantation

Background:

  • Humanized mouse models have significantly advanced the study of the human hemato-lymphoid system.
  • These models are vital for identifying hematopoietic stem cells and understanding hematopoietic hierarchy.

Purpose of the Study:

  • To review the achievements and developments in humanized mouse models for preclinical research.
  • To highlight the remaining challenges in creating predictive xenogeneic models for human hematology and immunology.

Main Methods:

  • Improvements in xenograft models focus on host tolerance, niche creation, and support factors like cytokines.
  • Experimental approaches include genetic modification of mice, co-transplantation of stem cells, and implantation of human tissues.

Main Results:

  • Humanized mice have been instrumental in identifying normal and leukemic hematopoietic stem cells.
  • These models are used for preclinical therapy testing in malignant hematopoietic disorders.

Conclusions:

  • Xenograft models are increasingly sophisticated tools for human hematology and immunology research.
  • Further development is needed to create highly predictive preclinical systems that closely mimic the human condition.